You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pancreatic neuroendocrine NET

Showing 1 - 25 of 5,375
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,

Recruiting
  • Neuroendocrine Tumors
  • +4 more
  • [212Pb] VMT-α-NET
  • [203Pb] VMT-α-NET SPECT/CT
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center at the University of Iowa
Nov 30, 2023

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

Not yet recruiting
  • Neuroendocrine Tumors
  • +8 more
  • Iowa City, Iowa
  • +1 more
Nov 23, 2022

68Ga-DOTATOC Radio-Guided Surgery With ß-Probe in GEP-NET

Recruiting
  • Neuroendocrine Tumor Carcinoid
  • +2 more
    • Milan, Italy
      IRCCS Istituto Europeo di Oncologia S.r.l.
    Jul 8, 2022

    Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +4 more
    • Newport Beach, California
    • +2 more
    Aug 16, 2023

    Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

    Not yet recruiting
    • Small Cell Lung Cancer (SCLC)
    • +3 more
    • (no location specified)
    Dec 7, 2022

    GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease Trial in United States

    Recruiting
    • GEP-NET
    • +6 more
    • Duarte, California
    • +3 more
    Jul 28, 2022

    Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))

    Suspended
    • Gastroenteropancreatic Neuroendocrine Tumor
    • Stanford, California
      Stanford Cancer Institute Palo Alto
    Sep 21, 2022

    Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)

    Not yet recruiting
    • Advanced Gastroenteropancreatic Neuroendocrine Tumor
    • (no location specified)
    Oct 16, 2023

    Gastroenteropancreatic Neuroendocrine Tumours

    Recruiting
    • Gastroenteropancreatic Neuroendocrine Tumor
    • 68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included
    • Milano, Italy
      Irccs San Raffaele
    Nov 24, 2023

    Collect Somatuline® Injector Device Preferences of Patients

    Not yet recruiting
    • Neuroendocrine Tumors
      • (no location specified)
      Jun 19, 2023

      Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1 Trial ([203Pb]VMT-a-NET, SPECT/CT)

      Enrolling by invitation
      • Neuroendocrine Tumor Grade 2
      • Neuroendocrine Tumor Grade 1
      • Iowa City, Iowa
        The University of Iowa
      Dec 9, 2022

      Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

      Recruiting
      • Gastroenteropancreatico Tumors
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 19, 2023

      Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

      Not yet recruiting
      • Pancreatic Adenocarcinoma
      • +6 more
      • (no location specified)
      Aug 4, 2023

      Neuroendocrine Tumor Grade 3, Neuroendocrine Carcinoma, Pancreatic Carcinoma Trial in Tianjin (Surufatinib, Sintilimab)

      Recruiting
      • Neuroendocrine Tumor Grade 3
      • +2 more
      • Tianjin, Tianjin, China
        Rui Liu
      Nov 17, 2022

      Multi-dimensional Fragmentomic Assay for Early Detection of

      Not yet recruiting
      • Pancreatic Neuroendocrine Tumor
      • Fragmentomic profiles of plasma cfDNA
      • (no location specified)
      Apr 27, 2023

      Development of New Personalised 3D Preclinical Models of

      Recruiting
      • Pancreatic Neuroendocrine Tumor
        • Milan, MI, Italy
          IRCCS San Raffele Institute
        Nov 2, 2023

        Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)

        Completed
        • Pancreatic Neuroendocrine Tumor G2
        • Octreotide LAR
        • (no location specified)
        Oct 17, 2023

        Pancreatic Neuroendocrine Tumor, Pancreas Cancer Trial in Chicago (cytoreductive surgery, Lutathera - a small molecule used in

        Not yet recruiting
        • Pancreatic Neuroendocrine Tumor
        • Pancreas Cancer
        • cytoreductive surgery
        • +2 more
        • Chicago, Illinois
          The University of Chicago
        Nov 8, 2022

        Well-differentiated Non-functional NET of Thoracic Origin, Well-differentiated Non-functional NET of Gastrointestinal Origin,

        Completed
        Has Results
        • Well-differentiated Non-functional NET of Thoracic Origin
        • +3 more
        • Duarte, California
        • +34 more
        Mar 16, 2021

        Pancreatic Neuroendocrine Tumor Trial in Milano (peptide receptor radionuclide therapy with Y-90-DOTATOC)

        Recruiting
        • Pancreatic Neuroendocrine Tumor
        • peptide receptor radionuclide therapy with Y-90-DOTATOC
        • Milano, Italy
        • +1 more
        Sep 30, 2022

        Neuroendocrine Tumours (NET), Neuroendocrine Carcinomas (NEC) Trial in Spain (177Lu-Dotatate, Nivolumab)

        Recruiting
        • Neuroendocrine Tumours (NET)
        • Neuroendocrine Carcinomas (NEC)
        • Santiago De Compostela, Galicia, Spain
        • +4 more
        Aug 1, 2022

        Metastatic Midgut Neuroendocrine Tumor, Unresectable Midgut Neuroendocrine Tumor Trial (procedure, drug, other)

        Not yet recruiting
        • Metastatic Midgut Neuroendocrine Tumor
        • Unresectable Midgut Neuroendocrine Tumor
        • Biospecimen Collection
        • +5 more
        • (no location specified)
        Mar 16, 2023

        Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (Lutetium (177Lu) Oxodotreotide Injection;long-acting Octreotide,

        Not yet recruiting
        • Advanced Gastroenteropancreatic Neuroendocrine Tumor
        • Lutetium (177Lu) Oxodotreotide Injection；long-acting Octreotide
        • long-acting Octreotide.
        • (no location specified)
        May 22, 2023

        Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

        Not yet recruiting
        • Digestive System Neuroendocrine Tumor G1
        • +5 more
        • Tumor Debulking
        • +5 more
        • Nashville, Tennessee
          Vanderbilt University/Ingram Cancer Center
        Aug 23, 2023

        Non-functional Neuroendocrine Tumors of Pancreatic Body and Tail

        Recruiting
        • Non Functioning Pancreatic Endocrine Tumor
        • Histopathological review, long-term prognosis and quality of life follow-up
        • Shanghai, Shanghai, China
          Department of Pancreatic Surgery, Fudan University Shanghai Canc
        Jun 8, 2023